Protected: Capital Blue Cross – Medical policy update (Infliximab (remicade, infelectra) and Natalizumab (tysabri); Small Group Renewal Changes; FSA Administration Updates

Protected: Capital Blue Cross – Medical policy update (Infliximab (remicade, infelectra) and Natalizumab (tysabri); Small Group Renewal Changes; FSA Administration Updates

  • On October 23, 2017

This content is password protected. To view it please enter your password below:

print